Published in Women's Health Weekly, September 1st, 1997
Dr. Fabio Landoni and colleagues, from Milan, Italy, reported the results of a randomized trial of two treatments for early cervical cancer that show that a combination of the two therapies give the worst complications and that menopausal status, age, medical illness, type of cancer, and cervical diameter need to be considered before optimum therapy can be chosen (The Lancet, August 23, 1997, vol 350, no. 9077).
Of 343 women with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.